产品说明书

SPDP

Print
Chemical Structure| 68181-17-9 同义名 : -
CAS号 : 68181-17-9
货号 : A104705
分子式 : C12H12N2O4S2
纯度 : 97%
分子量 : 312.36
MDL号 : MFCD00009636
存储条件:

粉末 Keep in dark place,Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 150 mg/mL(480.22 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. It is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs)[2]. DAC micelles were chemically linked onto the PAA-BP-modified stents by using N-succinimidyl-3-(2-pyridyldithiol)-propionate (SPDP) as a crosslinker[3]. The Vi (capsular polysaccharide) was bound to the porins by a heterobifunctional cross-linking reagent, N-succinimidyl-3-(2-pyridyl dithio)-propionate (SPDP)[4]. Based on the results obtained from morphological characterization, in vitro release, and therapeutic efficacy in cells, N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)-modified ABNs (ABN-SPDP) was chosen. Since ABN-SPDP are formed with disulfide linkage, the drug release is facilitated under a highly reducing environment present in the tumor sites[5].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01166048 Chronic Low Back Pain Phase 4 Completed - Austria ... 展开 >> Department of Special Anesthesia and Pain Therapy, Medical University of Vienna, AKH Vienna Vienna, Austria, 1090 收起 <<
NCT02968433 Parkinson Disease(PD) Phase 1 Active, not recruiting December 2018 United States, California ... 展开 >> Stanford Movement Disorders Clinic Stanford, California, United States, 94304 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.20mL

0.64mL

0.32mL

16.01mL

3.20mL

1.60mL

32.01mL

6.40mL

3.20mL

参考文献

[1]Yan SG, Chen XL, et al. [Spectral changes of C-phycocyanin with different molar ratios of SPDP] . Guang Pu Xue Yu Guang Pu Fen Xi. 2008 May;28(5):1115-7.

[2]Ciano M, Fuszard M, Heide H, Botting CH, Galkin A. Conformation-specific crosslinking of mitochondrial complex I. FEBS Lett. 2013 Apr 2;587(7):867-72

[3]Ma G, Wang Y, Fishbein I, Yu M, Zhang L, Alferiev IS, Yang J, Song C, Levy RJ. Anchoring of self-assembled plasmid DNA/anti-DNA antibody/cationic lipid micelles on bisphosphonate-modified stent for cardiovascular gene delivery. Int J Nanomedicine. 2013;8:1029-35

[4]Singh M, Ganguly NK, Kumar L, Vohra H. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi. Microbiol Immunol. 1999;43(6):535-42

[5]Prajapati R, Garcia-Garrido E, Somoza Á. Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer. Cancers (Basel). 2021 Jun 16;13(12):3011